Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Leukemia|November 9, 2022
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphomaWendan Xu, Philipp Berning, Tabea Erdmann, et al.Science (New York, N.Y.)|October 15, 2011
Sequential establishment of stripe patterns in an expanding cell populationChenli Liu, Xiongfei Fu, Lizhong Liu, et al.Genes & Development|October 8, 2011
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigationsHua Jing, Julia Kase, Jan R Dörr, et al.Proceedings of the National Academy of Sciences of the United States of America|July 11, 2013
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphomaMatthias Pfeifer, Michael Grau, Dido Lenze, et al.Cancer Discovery|September 26, 2014
Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferationKristina Heinig, Marcel Gätjen, Michael Grau, et al.Blood|July 23, 2013
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCLHendrik Nogai, Sören-Sebastian Wenzel, Stephan Hailfinger, et al.Leukemia|January 5, 2023
Molecular profiling of EBV associated diffuse large B-cell lymphomaFabian Frontzek, Annette M Staiger, Ramona Wullenkord, et al.Blood|November 1, 2014
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphomaAndre Weilemann, Michael Grau, Tabea Erdmann, et al.Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphomaStephan Kreher, M Amine Bouhlel, Pierre Cauchy, et al.Blood|February 17, 2017
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCLTabea Erdmann, Pavel Klener, James T Lynch, et al.Pageof 7